Literature DB >> 17364092

A novel radiographic method to facilitate measurement of the tibial plateau angle in dogs. A prospective clinical study.

J Headrick1, J Cook, M Helphrey, D Crouch, D Fox, L Schultz, C Cook, J Kunkel.   

Abstract

The tibial plateau levelling osteotomy (TPLO) is commonly performed for treatment of cranial cruciate ligament deficiency in dogs. In order to be performed as described, this procedure relies on consistent measurement of the tibial plateau angle (TPA) on radiographs. This prospective study compared two radiographic methods for subsequent TPA measurement with respect to measured angle and ease of determining landmarks for measurement as determined by four observers. One method was the accepted standard radiographic protocol outlined in the TPLO training seminars. The other method involved a novel split image radiographic protocol not yet described in the literature. Participants' subjective scores as to ease of identifying landmarks and determining TPA on radiographs for each method were evaluated. Inter-observer TPA measurement variability was also assessed for each method. The novel radiographic method was judged to be significantly better in terms of ease of measuring TPA. Inter-observer measurement variability was considered appropriate for recommending use of this novel method for radiographing patients for TPA measurements.

Entities:  

Mesh:

Year:  2007        PMID: 17364092

Source DB:  PubMed          Journal:  Vet Comp Orthop Traumatol        ISSN: 0932-0814            Impact factor:   1.358


  2 in total

1.  Preoperative planning using computed tomography in tibial plateau levelling osteotomy: A comparison with conventional radiography.

Authors:  Jayon Kim; Jaeeun Ko; Kidong Eom; Jaehwan Kim
Journal:  Vet Med Sci       Date:  2022-01-06

2.  Long-term outcome of tibial plateau leveling osteotomy using an antimicrobial silver-based coated plate in dogs.

Authors:  Geoffrey Pagès; Meike Hammer; Jean-Guillaume Grand; Iban Irubetagoyena
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.